SHIFT AI Newsroom · GLOBAL
New Review of Pharmacotherapies for Adolescent Obesity
A recent evidence-based review explores current and forthcoming pharmacotherapies for adolescent obesity, highlighting the need for further research and consideration of treatment options.
A recent evidence-based review published on Europe PMC discusses current and forthcoming pharmacotherapies for adolescent obesity. The review highlights the need for further research and consideration of treatment options. However, the specific pharmacotherapies discussed in the review are not specified, and their regulatory status and potential NHS commissioning status in the UK are unknown.
What this means in the UK
The review is relevant to the UK as it discusses potential treatment options for adolescent obesity, a growing concern in the country.
Known facts
- A recent review has been published on current and forthcoming pharmacotherapies for adolescent obesity.